Ogkologos

4398 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

R2-ISS: an Improved and Simple Prognostic Staging System Allows Better Stratification...

Ogkologos - 1 Ιουνίου, 2022

New study supports extending cervical screening intervals for people who test...

Ogkologos - 31 Μαΐου, 2022

What to Expect During a Skin Cancer Screening

Ogkologos - 31 Μαΐου, 2022

Lorlatinib in First-Line Treatment of Patients with Advanced ALK-Positive NSCLC With...

Ogkologos - 30 Μαΐου, 2022

What Are Clinical Practice Guidelines and How Do They Impact Care...

Ogkologos - 27 Μαΐου, 2022

Cancer in Lymph Nodes May Help Tumors Spread by Enlisting Immune...

Ogkologos - 27 Μαΐου, 2022

EMA Recommends Extension of Therapeutic Indications for Axicabtagene Ciloleucel

Ogkologos - 27 Μαΐου, 2022

Reunión anual de la ASCO de 2022: Gasto en servicios sociales...

Ogkologos - 26 Μαΐου, 2022

2022 ASCO Annual Meeting: Social Services Spending and Cancer Survival, Clinical...

Ogkologos - 26 Μαΐου, 2022

Five Questions With…Fern, Christina, Mary, and Shelley.

Ogkologos - 26 Μαΐου, 2022

1...196197198...440 Σελίδα 197 από 440

MOST POPULAR

A Third Of Breast Cancer Survivors Have Vaginal Atrophy, But Most...

15 Μαΐου, 2020

Carvykti Approval Marks Second CAR T-Cell Therapy for Multiple Myeloma

30 Μαρτίου, 2022

Learning the lessons of COVID-19: Protecting cancer services and research through...

9 Νοεμβρίου, 2020

Record Impact Factor for Annals of Oncology Highlights Growing Influence of...

2 Ιουλίου, 2026

Φόρτωση περισσοτέρων

R2-ISS: an Improved and Simple Prognostic Staging System Allows Better Stratification...

New study supports extending cervical screening intervals for people who test...

What to Expect During a Skin Cancer Screening

Lorlatinib in First-Line Treatment of Patients with Advanced ALK-Positive NSCLC With...

What Are Clinical Practice Guidelines and How Do They Impact Care...

Cancer in Lymph Nodes May Help Tumors Spread by Enlisting Immune...

EMA Recommends Extension of Therapeutic Indications for Axicabtagene Ciloleucel

Reunión anual de la ASCO de 2022: Gasto en servicios sociales...

2022 ASCO Annual Meeting: Social Services Spending and Cancer Survival, Clinical...

Five Questions With…Fern, Christina, Mary, and Shelley.

MOST POPULAR

A Third Of Breast Cancer Survivors Have Vaginal Atrophy, But Most...

Carvykti Approval Marks Second CAR T-Cell Therapy for Multiple Myeloma

Learning the lessons of COVID-19: Protecting cancer services and research through...

Record Impact Factor for Annals of Oncology Highlights Growing Influence of...

HOT NEWS

FDA Approves Nivolumab and Ipilimumab Combination for Advanced Kidney Cancer

Study Improves the Quality of Biopsy Specimens for Cancer Research

BRCA1/2 Pathogenic Variant Carriers with Serous Tubal Intraepithelial Carcinoma at Risk-Reducing...

EMA Recommends Extension of Indications for Inotuzumab Ozogamicin

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ